Claes Soderlund1, Stefan Linder. 1. Karolinska Institutet, Upper GI Surgery, Department of Surgery, South Hospital, SE 118-83 Stockholm, Sweden.
Abstract
BACKGROUND: Most patients with malignant common bile duct strictures are suited only for palliation of jaundice by placement of a polyethylene (PE) stent using an endoscopic retrograde cholangiographic technique. Occlusion of these stents occurs after 3 to 4 months, whereas uncovered self-expanding metal stents (SEMS) remain open twice as long. The initial higher cost of the latter might be balanced by a decreased need for repeat intervention. OBJECTIVE: To compare the patency of 10F PE stents and covered 30F steel SEMS (Wallstent; Boston Scientific Nordic AB, Helsingborg, Sweden). DESIGN: Single-center, prospective, randomized, controlled trial. SETTING: General hospital in Stockholm, Sweden, which has a catchment area of 0.6 million people. PATIENTS: Non-referred, unresectable malignant common bile duct strictures. INTERVENTIONS:Endoscopic retrograde cholangiography with plastic stents or covered SEMS. MAIN OUTCOME MEASUREMENTS: Time to stent failure, requiring a new stent. LIMITATIONS: Similar setting and patients, and costs in Scandinavia. RESULTS:Fifty-one and 49 patients were allocated to the PE stent and SEMS groups, respectively. Fifty-six patients died without stent failure within 10 months (median, 2.6 months). Twenty-two PE stent and 9 SEMS patients (P = .009) developed failure after a median of 1.1 and 3.5 months, respectively (P = .007). Median patency times were 1.8 and 3.6 months in the PE and SEMS groups, respectively (P = .002). Median survival was 4.5 months; in 35 patients with distant metastases, the median survival was 2.5 months (P = .002)(PE group, 1.9 months). CONCLUSIONS: The more-effective SEMS are recommended in unresectable patients with malignant common bile duct strictures, who survive a median of 4.5 months. Less costly plastic stents are preferable in the one third of patients who have distant metastases. In our study, the cost was equal.
RCT Entities:
BACKGROUND: Most patients with malignant common bile duct strictures are suited only for palliation of jaundice by placement of a polyethylene (PE) stent using an endoscopic retrograde cholangiographic technique. Occlusion of these stents occurs after 3 to 4 months, whereas uncovered self-expanding metal stents (SEMS) remain open twice as long. The initial higher cost of the latter might be balanced by a decreased need for repeat intervention. OBJECTIVE: To compare the patency of 10F PE stents and covered 30F steel SEMS (Wallstent; Boston Scientific Nordic AB, Helsingborg, Sweden). DESIGN: Single-center, prospective, randomized, controlled trial. SETTING: General hospital in Stockholm, Sweden, which has a catchment area of 0.6 million people. PATIENTS: Non-referred, unresectable malignant common bile duct strictures. INTERVENTIONS: Endoscopic retrograde cholangiography with plastic stents or covered SEMS. MAIN OUTCOME MEASUREMENTS: Time to stent failure, requiring a new stent. LIMITATIONS: Similar setting and patients, and costs in Scandinavia. RESULTS: Fifty-one and 49 patients were allocated to the PE stent and SEMS groups, respectively. Fifty-six patients died without stent failure within 10 months (median, 2.6 months). Twenty-two PE stent and 9 SEMS patients (P = .009) developed failure after a median of 1.1 and 3.5 months, respectively (P = .007). Median patency times were 1.8 and 3.6 months in the PE and SEMS groups, respectively (P = .002). Median survival was 4.5 months; in 35 patients with distant metastases, the median survival was 2.5 months (P = .002)(PE group, 1.9 months). CONCLUSIONS: The more-effective SEMS are recommended in unresectable patients with malignant common bile duct strictures, who survive a median of 4.5 months. Less costly plastic stents are preferable in the one third of patients who have distant metastases. In our study, the cost was equal.
Authors: Ali A Siddiqui; Jayaprakash Sreenarasimhaiah; Luis F Lara; William Harford; Calvin Lee; Mohamad A Eloubeidi Journal: Surg Endosc Date: 2010-07-15 Impact factor: 4.584
Authors: Margaret A Tempero; J Pablo Arnoletti; Stephen Behrman; Edgar Ben-Josef; Al B Benson; Jordan D Berlin; John L Cameron; Ephraim S Casper; Steven J Cohen; Michelle Duff; Joshua D I Ellenhorn; William G Hawkins; John P Hoffman; Boris W Kuvshinoff; Mokenge P Malafa; Peter Muscarella; Eric K Nakakura; Aaron R Sasson; Sarah P Thayer; Douglas S Tyler; Robert S Warren; Samuel Whiting; Christopher Willett; Robert A Wolff Journal: J Natl Compr Canc Netw Date: 2010-09 Impact factor: 11.908
Authors: Peter L Moses; Khalid M Alnaamani; Alan N Barkun; Stuart R Gordon; Roger D Mitty; M Stanley Branch; Thomas E Kowalski; Myriam Martel; Viviane Adam Journal: World J Gastroenterol Date: 2013-12-14 Impact factor: 5.742
Authors: Thiago F Nunes; Rômulo F T Santos; Tiago K Tibana; Thiago A Domingos; Edson Marchiori; Vinicius A V Fornazari; Joaquim Maurício da Motta-Leal-Filho; Denis Szejnfeld Journal: Abdom Radiol (NY) Date: 2020-06-30
Authors: Mehrdad Nikfarjam; Andrew K Hadj; Vijayaragavan Muralidharan; Niall Tebbutt; Michael A Fink; Robert M Jones; Graham Starkey; Rhys B Vaughan; Alexander W Marshall; Christopher Christophi Journal: Indian J Gastroenterol Date: 2012-11-16